Protocol for a Multicenter Study on (Cost)Effectiveness of the Back At Work After Surgery (BAAS): a Clinical Pathway for Knee Arthroplasty

Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Jan 10, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new program called the Back At Work After Surgery (BAAS) pathway, which aims to help people return to work more effectively after knee replacement surgery, also known as knee arthroplasty. The researchers want to find out how well this program works compared to regular care, especially in terms of how quickly and successfully patients can get back to their jobs after surgery. They will be looking at patients who are scheduled for either total knee arthroplasty or partial knee arthroplasty and who have been working at least eight hours a week before their surgery.

To participate, patients need to be between 18 and 65 years old, planning to return to work after their surgery, and have knee issues related to arthritis. Those with certain medical conditions that could affect their ability to work after surgery or those who have undergone multiple medical events in the past year will not be included. If you choose to participate, you will receive detailed information about the study and have the chance to ask questions. You will be given a week to think about your decision before confirming your participation. This trial is currently recruiting participants, and it’s designed to help improve recovery and return-to-work outcomes for knee surgery patients.

Gender

ALL

Eligibility criteria

• • nclusion criteria for patients are: (ii) being scheduled for primary or revision UKA or TKA by an orthopedic surgeon between January 2022 and July 2023; (ii) having paid work for at least eight hours a week before surgery; (iii) being between 18 and 65 years of age and (iv) having the intention to fully RTW after surgery. Criteria to exclude patients are: (i) receiving more than one medical event within one year that affects work ability after KA; (ii) having a KA for any other reason than knee osteoarthritis; and (iii) having major disabling mental disorders. Patients who do not speak or read Dutch are given the opportunity to fill in the questionnaires with the aid of a translator and to have an interpreter present during the consultations. Patients who are eligible to participate are informed about the study by telephone by the medical case manager (MCM; physical therapist working in the hospital). During an intake consultation with an MCM, the patient information letter, informed consent, and an infographic of the BAAS clinical pathway (Appendix I) are handed out to the patient. Patients' questions regarding participation are answered. Patients are given one week to decide whether or not they wish to participate. Patients who opted for the possibility to participate receive a telephone call after one week so that they can ask any additional questions about the study and they will be asked if they want to participate. Participants willing to participate sign the informed consent.